Epilepsy Clinical Trial
Official title:
Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit
Verified date | March 2017 |
Source | New York University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary goal of the study is to assess the effect of pre-oxygenation on oxygen and
carbon dioxide levels during seizures in patients admitted at the Epilepsy Monitoring Unit
(EMU). The investigators hypothesize that providing oxygen prior to seizures will help
eliminate the drops in changes seen during seizures, such as the drop in oxygen saturation
and increase in carbon dioxide levels.
Research will be done on patients that are admitted to the EMU specifically to have seizures
occur and to be recorded on video electroencephalography (vEEG), and the only research
intervention will be the use of oxygen prior to some of the seizures.
The importance of this research relates to the phenomenon of sudden unexplained death in
epilepsy patients (SUDEP). SUDEP cases are typically patients with epilepsy who are found
dead by their families in the morning, without a clear cause for death. The risk of SUDEP is
as high as 9.3 per 1000 person-years (Shorvon and Tomson 2011). There may be multiple
mechanisms for SUDEP to occur, however a leading hypothesis is a decrease in ventilation
during the seizure leading to hypoxia. Blood oxygen saturation levels have been found to
decrease significantly in 25-50% of patients during or shortly after a seizure while being
monitored in hospitals. In rare situations, a significantly lowered oxygen level may trigger
a cascade of events from which the body may not be able to recover, leading to SUDEP. In
animal models, providing oxygen prior to seizures occurring has been shown to eliminate
oxygen desaturation, but more importantly eliminate mortality in animals prone to death due
to seizures.
Pre-oxygenation is a standard procedure during rapid-sequence induction anesthesia as it
reduces the risk of oxygen desaturation during the apneic period of the procedure. On room
air, the estimated duration of safe apnea is 1 minute, but this can increase to 8 minutes
following pre-treatment with high FiO2 (Weingart and Levitan 2012). This is primarily due to
oxygen replacing nitrogen within alveoli, creating a reservoir of oxygen within the lungs
from which transfer to the bloodstream can continue despite the lack of ventilation. The
apneic episode during seizures should benefit from the same principle.
The main purpose of the Epilepsy Monitoring Unit (EMU) is to evaluate patients to better
characterize seizures, to identify the main seizure focus. In addition to standard EEG with
electrodes on the scalp, some patients require invasive localization of the epileptic focus
by surgically placing electrodes within the skull (often referred to as GRID patients) on or
within the brain, with the goal of being able to resect the area that is causing seizures.
To identify where seizure originate electrically, it requires that seizures occur during the
vEEG procedure. To provoke seizures, medications are typically lowered, and both partial
seizures and those with secondary generalization to full tonic-clonic (GTC) seizures will
occur. Prior research has shows that oxygen desaturation below 90% occurs with some complex
partial seizures, but hypoxia is more common and more profound with GTCs. Some centers use
oxygen saturation and CO2 monitors as their standard of care, and at NYULMC the
investigators also have the capability for both for clinical usage.
Oxygen is not currently a mandated standard-of-care, but is often provided by nasal prongs
following seizures as part of the post-ictal nursing care, though there is no outcome data
to support its use. It is unknown whether pre-treatment with oxygen will reduce the rate of
oxygen desaturations clinically, as seen in animal models, and this is the goal of this
research project.
Status | Terminated |
Enrollment | 5 |
Est. completion date | March 2016 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - patients aged 18-70 yo admitted for monitoring and capturing seizures at the EMU with scalp electrodes and for seizure localization with implantation of intracranial electrodes. Exclusion Criteria: - patients who are considered healthy enough to provoke seizure activity will have few medical illnesses severe enough to be of concern with respect to continuous oxygen delivery. However, patients will be screened for moderate to severe chronic obstructive pulmonary disease and excluded, as their minute ventilation may decrease and CO2 levels increased with continuous oxygen supplementation. |
Country | Name | City | State |
---|---|---|---|
United States | NYU Langone Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
New York University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oxygen desaturation below 92% following GTCs | during and up to 6 minutes following the seizure | ||
Secondary | Oxygen Desaturations below 80% following GTCs | during and up to 6 minutes following seizures |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |